|
ZDHHC17 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.635390E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.646100E-02 |
| Normal-vs-Stage2 |
3.837400E-01 |
| Normal-vs-Stage3 |
1.487440E-01 |
| Normal-vs-Stage4 |
5.370800E-01 |
| Stage1-vs-Stage2 |
6.197600E-01 |
| Stage1-vs-Stage3 |
8.517600E-01 |
| Stage1-vs-Stage4 |
6.020400E-01 |
| Stage2-vs-Stage3 |
7.705200E-01 |
| Stage2-vs-Stage4 |
9.070400E-01 |
| Stage3-vs-Stage4 |
6.901400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.366250E-01 |
| Normal-vs-AfricanAmerican |
3.951600E-01 |
| Normal-vs-Asian |
3.616600E-01 |
| Caucasian-vs-AfricanAmerican |
4.369200E-01 |
| Caucasian-vs-Asian |
9.376400E-01 |
| AfricanAmerican-vs-Asian |
7.443000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.253900E-02 |
| Normal-vs-Female |
7.157200E-01 |
| Male-vs-Female |
5.166300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.714190E-01 |
| Normal-vs-Extreme_Weight |
2.568000E-02 |
| Normal-vs-Obese |
3.166200E-01 |
| Normal-vs-Extreme_Obese |
4.818100E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.178800E-01 |
| Normal_Weight-vs-Obese |
6.411200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.502400E-01 |
| Extreme_Weight-vs-Obese |
1.465650E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.502800E-01 |
| Obese-vs-Extreme_Obese |
2.893200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.901200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.114200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.957800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.099600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.394600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.651730E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.807660E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.608420E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.247950E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.915200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.745200E-01 |
| Normal-VS-Type2 PRCC |
1.628380E-04 |
| Normal-VS-KIRP CIMP |
8.544800E-01 |
| Normal-VS-Unclassified PRCC |
9.890400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.024700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
7.397200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.776800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.686100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.622700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.828000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.040400E-03 |
| Normal-vs-N1 |
6.883600E-01 |
| Normal-vs-N2 |
3.022000E-01 |
| N0-vs-N1 |
1.807670E-02 |
| N0-vs-N2 |
7.531800E-01 |
| N1-vs-N2 |
3.815800E-01 |
|
|
